ReviewCurrent oncology (Toronto, Ont.)2026

Early Experience with Tarlatamab (T-Cell Engagers) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Canada: Lessons Learned and Implementation Strategies.

Parneet K Cheema et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.